← Open Payments lookup

ADAM KORENKE: Open Payments

NPI 1417995937 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$361 in 16 payments from 10 companies in 2025. Trend: 2023 $150 · 2024 $248 · 2025 $361

Food & beverage: $361
CompanyPaymentsAmount
PFIZER INC.6$119
ARRAY BIOPHARMA INC2$43
E.R. Squibb & Sons, L.L.C.1$34
Deciphera Pharmaceuticals Inc.1$32
Regeneron Healthcare Solutions, Inc.1$28
Gilead Sciences, Inc.1$24
Karyopharm Therapeutics Inc.1$21
Novartis Pharmaceuticals Corporation1$20
Exelixis Inc.1$20
Merck Sharp & Dohme LLC1$19

Products named: XTANDI, XALKORI, OPDIVO, PADCEV, QINLOCK, LIBTAYO, Trodelvy, INLYTA.

Industry payments across TX — which companies pay providers there.